Mary Slack - Concepedia

Author

Mary Slack

Also Known As

M P E Slack, M P Slack, M Slack, M. P. E. SLACK, M. P. E. Slack, M. P. Slack, M. SLACK, M. Slack, M.P.E. Slack, M. P. SLACK

243

Publications

10.6K

Citations

H-Index

Concepts

All Affiliations

Public Health England John Radcliffe Hospital University of Oxford St George's, University of London Health Protection Agency

About

Mary Slack is an author at Public Health England specializing in medicine, infection control, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	51	4.3K
2	Public Health	16	17	904
3	Health Sciences	8	8	555
4	Engineering	2	2	32
5	Allergy	1	1	23

Mary Slack

106

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Bacteremia among Children Admitted to a Rural Hospital in Kenya James A. Berkley, Brett Lowe, Isaiah Mwangi, New England Journal of Medicine	2005	852
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study Elizabeth Miller, Nicholas J. Andrews, Pauline A. Waight, The Lancet Infectious Diseases VaccinationVaccinologyPreventive MedicineVaccine DevelopmentObservational Cohort Study	2011	641
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study Pauline A. Waight, Nicholas J. Andrews, Shamez Ladhani, The Lancet Infectious Diseases	2015	589
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study Nick Andrews, Pauline A. Waight, Polly Burbidge, The Lancet Infectious Diseases VaccinationVaccine SafetyPreventive MedicineVaccine EfficacyInfection Control	2014	538
Inhibition of tobramycin diffusion by binding to alginate Wright W. Nichols, Susan M. Dorrington, Mary Slack, Antimicrobial Agents and Chemotherapy Tobramycin DiffusionExopolysaccharide ConcentrationAntimicrobial SusceptibilityHealth SciencesAntibiotics	1988	295
The Penetration of Antibiotics into Aggregates of Mucoid and Non-mucoid Pseudomonas aeruginosa Wright W. Nichols, Michael J. Evans, Mary Slack, Microbiology	1989	251
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales Nick Andrews, Pauline A. Waight, Robert C. George, Vaccine VaccinologyVaccine SafetyVaccinationInvasive Pneumococcal DiseaseVaccine Surveillance	2012	237
Invasive<i>Haemophilus influenzae</i>Disease, Europe, 1996–2006 Shamez Ladhani, Mary Slack, Paul T. Heath, Emerging infectious diseases	2010	211
Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine Elizabeth Miller, Nicholas J. Andrews, Pauline A. Waight, Vaccine VaccinationVaccine DevelopmentImmunologyNew SerotypesInfection Control	2011	207
Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction Into Routine Childhood Immunization in Kenya Karen Cowgill, Moses Ndiritu, Joyce U. Nyiro, JAMA	2006	184

Page 1